Skip to content
PIL Logo

ZYDOL 50 mg/ml Solution for Injection

Last Updated on eMC 10-Aug-2016 View document  | Grunenthal Ltd Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 10-Aug-2016 and displayed until Current

Reasons for adding or updating:

  • Change to section 6 - date of revision
  • Change to name of medicinal product

Updated on 12-Feb-2015 and displayed until 10-Aug-2016

Reasons for adding or updating:

  • Change to section 2 - driving and using machines

Updated on 20-Aug-2014 and displayed until 12-Feb-2015

Reasons for adding or updating:

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 2 - driving and using machines
  • Change to section 3 - dose and frequency
  • Change to section 3 - overdose, missed or forgotten doses
  • Change to section 4 - possible side effects
  • Change to section 6 - what the product looks like and pack contents
  • Change to section 6 - date of revision

Updated on 31-Jan-2014 and displayed until 20-Aug-2014

Reasons for adding or updating:

  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 4 - possible side effects
  • Change to section 4 - how to report a side effect
  • Change to section 6 - date of revision

Updated on 31-Oct-2013 and displayed until 31-Jan-2014

Reasons for adding or updating:

  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 3 - how to take/use
  • Change to section 6 - date of revision

Updated on 02-Feb-2011 and displayed until 31-Oct-2013

Reasons for adding or updating:

  • Change to date of revision
  • Change to instructions about overdose
  • Change to side-effects

Updated on 24-Jun-2010 and displayed until 02-Feb-2011

Reasons for adding or updating:

  • Change to Further Information section

Updated on 25-Mar-2009 and displayed until 24-Jun-2010

Reasons for adding or updating:

  • Improved Electronic Presentation

Updated on 24-Mar-2009 and displayed until 25-Mar-2009

Reasons for adding or updating:

  • Change to date of revision

Updated on 04-Mar-2009 and displayed until 24-Mar-2009

Reasons for adding or updating:

  • Change/addition of instructions for reconstitution and/ or administration
  • Change due to harmonisation of PIL.
  • Change to how the medicine works
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to instructions about overdose
  • Change to side-effects
  • Change to drug interactions
  • Change to information about drinking alcohol
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
  • Change due to user-testing of patient information
  • Changes to therapeutic indications

Updated on 11-Sep-2006 and displayed until 04-Mar-2009

Reasons for adding or updating:

  • Change of contra-indications
  • Change to drug interactions

Updated on 04-Aug-2005 and displayed until 11-Sep-2006

Reasons for adding or updating:

  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Company contact details

Company image
Address

Units 1 and 2 Stokenchurch Business Park, Ibstone Road, Stokenchurch, Buckinghamshire, HP14 3FE, UK

Medical Information e-mail
Medical Information Direct Line

+44 (0)870 351 8960

Medical Information Fax

+44 (0)1494 486298

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

tramadol hydrochloride

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue